Though carried out on a limited number of GD and HT participants (255 patients), Inoue et al. suggested that several polymorphisms of the VDR gene may be involved in the development of HT and GD severity, thus supporting epidemiological findings [104]. The gene discussed is VDR; the disease is hematocrit.